ArticleCureus2025
COVID-19 Infection Induces Rhabdomyolysis and Acute Kidney Injury.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus disease 2019 (COVID-19) is an infectious illness caused by the SARS-CoV-2 virus. COVID-19 mainly affects the respiratory tract, and it can also lead to rhabdomyolysis and acute kidney injury as extrapulmonary complications. Rhabdomyolysis syndrome is caused by muscle necrosis and intracellular contents into the circulation. Rhabdomyolysis is frequently associated with trauma or crush injuries, and less frequently with infections. We report two cases of COVID-19-induced rhabdomyolysis at King Abdullah University Hospital in Jordan. Both patients presented at the emergency department with markedly elevated creatine phosphokinase levels, accompanied by breathlessness, cough, myalgias, and fatigue. They were admitted and treated with aggressive intravenous fluids. One patient progressed to respiratory failure, required mechanical ventilation, and died. The other responded well to treatment and made a full recovery. Medical professionals need to be aware that COVID-19 can lead to rhabdomyolysis and acute kidney injury, and in these situations, the patient needs to be appropriately treated and provided with fluids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.